Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
Purpose: We investigated serum cytokine and T-cell responses directed against tumour-associated antigens (TAAs) in association with survival of patients with glioblastoma multiforme (GBM). Patients and Methods: Peripheral blood from 205 treatment-naïve patients with glioma (GBM = 145; non-GBM = 60)...
Main Authors: | Liu Zhenjiang, Martin Rao, Xiaohua Luo, Davide Valentini, Anna von Landenberg, Qingda Meng, Georges Sinclair, Nina Hoffmann, Julia Karbach, Hans-Michael Altmannsberger, Elke Jäger, Inti Harvey Peredo, Ernest Dodoo, Markus Maeurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418302214 |
Similar Items
-
Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
by: Zhenjiang Liu, et al.
Published: (2018-07-01) -
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
by: Liu Zhenjiang, et al.
Published: (2017-09-01) -
Tumor-infiltrating lymphocytes (TILs) from patients with glioma
by: Zhenjiang Liu, et al.
Published: (2017-02-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01) -
Glioblastoma multiforme
by: Melissa Serra Ruíz, et al.
Published: (2019-04-01)